Smrithi Rajendiran

University of California, Santa Cruz, Santa Cruz, CA, United States 
"Smrithi Rajendiran"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Rodriguez Y Baena A, Rajendiran S, Manso BA, et al. (2022) New transgenic mouse models enabling pan-hematopoietic or selective hematopoietic stem cell depletion in vivo. Scientific Reports. 12: 3156
Rajendiran S, Boyer SW, Forsberg EC. (2020) A quantitative hematopoietic stem cell reconstitution protocol: Accounting for recipient variability, tissue distribution and cell half-lives. Stem Cell Research. 50: 102145
Rajendiran S, Smith-Berdan S, Kunz L, et al. (2020) Ubiquitous overexpression of CXCL12 confers radiation protection and enhances mobilization of hematopoietic stem and progenitor cells. Stem Cells (Dayton, Ohio)
Smith-Berdan S, Bercasio A, Rajendiran S, et al. (2019) Viagra Enables Efficient, Single-Day Hematopoietic Stem Cell Mobilization. Stem Cell Reports
Boyer SW, Rajendiran S, Beaudin AE, et al. (2019) Clonal and Quantitative In Vivo Assessment of Hematopoietic Stem Cell Differentiation Reveals Strong Erythroid Potential of Multipotent Cells. Stem Cell Reports
Rajendiran S, Boyer S, Beaudin A, et al. (2018) In Vivo Lineage Potential of Hematopoietic Stem and Progenitor Cells Using a Novel Quantification Method Suggests an Erythroid-Favored Differentiation Model Experimental Hematology. 64: S51
Kpetemey M, Dasgupta S, Rajendiran S, et al. (2015) MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression. Molecular Cancer. 14: 156
Rajendiran S, Kpetemey M, Maji S, et al. (2015) MIEN1 promotes oral cancer progression and implicates poor overall survival. Cancer Biology & Therapy. 16: 876-85
See more...